These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25778910)

  • 21. Five easy pieces on evidence-based medicine (4).
    Kalso E; Edwards J; McQuay HJ; Moore RA
    Eur J Pain; 2002; 6(1):89-93. PubMed ID: 11888232
    [No Abstract]   [Full Text] [Related]  

  • 22. Robust meta-analytic conclusions mandate the provision of prediction intervals in meta-analysis summaries.
    Graham PL; Moran JL
    J Clin Epidemiol; 2012 May; 65(5):503-10. PubMed ID: 22265586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simulation study comparing properties of heterogeneity measures in meta-analyses.
    Mittlböck M; Heinzl H
    Stat Med; 2006 Dec; 25(24):4321-33. PubMed ID: 16991104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective reporting of adjusted estimates in observational epidemiology studies: reasons and implications for meta-analyses.
    Peters J; Mengersen K
    Eval Health Prof; 2008 Dec; 31(4):370-89. PubMed ID: 19000980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Considerations for planning and designing meta-analysis in oral medicine.
    Pinto A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):194-202. PubMed ID: 23663987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology and statistics: recommendations to strengthen a productive partnership.
    Spector R; Vesell ES
    Pharmacology; 2006; 78(3):113-22. PubMed ID: 17008772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
    Smith CT; Williamson PR; Marson AG
    J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey.
    Ioannidis JP; Trikalinos TA
    CMAJ; 2007 Apr; 176(8):1091-6. PubMed ID: 17420491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods.
    Friedrich JO; Adhikari NK; Beyene J
    J Clin Epidemiol; 2011 May; 64(5):556-64. PubMed ID: 21447428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The practice of systematic reviews. V. Heterogeneity between studies and subgroup analysis].
    Scholten RJ; Assendelft WJ; Kostense PJ; Bouter LM
    Ned Tijdschr Geneeskd; 1999 Apr; 143(16):843-8. PubMed ID: 10347653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues in the meta-analysis of cluster randomized trials.
    Donner A; Klar N
    Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An empirical investigation of partial effect sizes in meta-analysis of correlational data.
    Aloe AM
    J Gen Psychol; 2014; 141(1):47-64. PubMed ID: 24838020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How should meta-regression analyses be undertaken and interpreted?
    Thompson SG; Higgins JP
    Stat Med; 2002 Jun; 21(11):1559-73. PubMed ID: 12111920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Meta-analysis as a tool for gaining knowledge].
    Koch A; Ziegler S
    Med Klin (Munich); 2000 May; 95(1 Spec No):83-90. PubMed ID: 10851854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HELOW: a program for testing extreme homogeneity in meta-analysis.
    Zintzaras E; Ioannidis JP
    Comput Methods Programs Biomed; 2014 Nov; 117(2):383-6. PubMed ID: 25023534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified.
    Coory MD
    Int J Epidemiol; 2010 Jun; 39(3):932; author reply 933. PubMed ID: 19349478
    [No Abstract]   [Full Text] [Related]  

  • 38. [Application of Stata software to test heterogeneity in meta-analysis method].
    Wang D; Mou ZY; Zhai JX; Zong HX; Zhao XD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):726-9. PubMed ID: 19031771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity in meta-analyses. Comparing apples and oranges?
    Choi SW; Lam DM
    Anaesthesia; 2017 Apr; 72(4):532-534. PubMed ID: 28213890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.